Inova Labs Receives CE Mark Approval for LifeChoice® Portable Oxygen Concentrator System

From PRNewswire.com

New Technology enables COPD patients to experience true portability while maintaining appropriate oxygen concentration levels during both day and night

Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) Market, announced today (Dec 1) that it has received CE Mark approval to begin marketing the LifeChoice® Portable Oxygen Concentrator System in Europe.

"This is a major milestone for our Company and for COPD patients who are on Long Term Oxygen Therapy," said John Rush, CEO of Inova Labs.  "The LifeChoice® technology allows patients to continue to live their daily lives with minimal disruption despite the advanced stage of their COPD disease."   

The Company is currently in discussions with potential partners in Europe and expects to begin marketing the LifeChoice® Technology in the region in early 2012.